Complete Schedule

International Food Allergy Symposium requires separate registration fee. Admission by ticket only.

Supported by an independent educational grant from DBV Technologies

Moderators: David R. Stukus, MD, FACAAI, and Matthew Greenhawt, MD, MSc, MBA, FACAAI

Prevention

Multiple countries now have recommendations for early allergenic solid food introduction to help prevent food allergy. However, these guidelines differ on what, when and how to introduce, providing conflicting information. Moreover, there are other emerging factors, beyond solid food introduction, which are not incorporated in the present guidelines but may be relevant to the prevention of food allergy. This session will review the evidence to date, discuss guideline discrepancies and present data on the horizon that goes beyond the present guidelines toward where the next breakthroughs may be, to educate attendees about where we stand in our ability to comprehensively help prevent food allergy development.

Assessing Prevalence

Methodologies in how to measure food allergy prevalence differ tremendously among westernized countries. Birth, infant and population-level cohorts are invaluable tools for the study of food allergy across a nationally-representative population, in particular to assess the prevalence of food allergy through the use of oral food challenges. However, the U.S. continues to lack such an approach. This session will detail how food allergy prevalence has been assessed using food challenge in three large international cohorts.

International Food Allergy Symposium requires separate registration fee. Admission by ticket only.

Supported by an independent educational grant from DBV Technologies

From the Horse’s Mouth – The FDA Perspective on Treatment and Unmet Needs

This lunchtime discussion will address regulatory aspects of food allergy that impact our patients on a daily basis.

Moderator: Warner W. Carr, MD, FACAAI

International Food Allergy Symposium requires separate registration fee. Admission by ticket only.

Supported by an independent educational grant from DBV Technologies

Moderators: David R. Stukus, MD, FACAAI and Matthew Greenhawt, MD, MSc, MBA, FACAAI

Treatment

There is a bright horizon for food allergy treatment, with commercial options for peanut allergy anticipated in the next year. Moreover, new approaches are under investigation in the clinical pipeline to help foster evolution in the treatment approach. It is important for parents and providers to understand what treatment options exist and how to communicate them and foster shared decision-making among patients regarding these options.

Bigger Success Begets Bigger Problems: Issues on the Horizon

With the development of new treatment options, there have been similar innovations made regarding new diagnostic testing to complement older, more established methods. Understanding the relative value, utility and costs associated with these approaches is imperative. Equally important is shaping the conversations with parents and patients, so that providers can anticipate and understand the information that patients are receiving outside of our scope of practice. This session will address these issues that are impacting current and future approaches to management.

International Food Allergy Symposium requires separate registration fee. Admission by ticket only.

Supported by an independent educational grant from DBV Technologies

Refreshments will be provided.

Not For Credit

Two allergists enter...one leaves. See leading experts in the field debate some of the hottest topics facing the field at present, Texas-style. This session will include three pro/con debates surrounding interesting and controversial topics related to food allergy immunotherapy. With beer! (This session is non-CME.)

Moderators: David R. Stukus, MD, FACAAI and Matthew Greenhawt, MD, MSc, MBA, FACAAI

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Presented by:
Jonathan Corren, MD
Ellen Sher, MD

Please join Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. for a Non-CME Forum presentation at the ACAAI Conference. Located at the Marriott Marquis Houston. Food and beverage to be served.

Also, visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313.

Supported by Aimmune Therapeutics

Not For Credit

Presented by:
Joel M. Hartman, MD
Jennifer Jobrack, Principal, The Food Allergy Pros, LLC
Douglas T. Johnston, DO
Bruce Joshua Lanser, MD

Increasing awareness of the challenges of living with food allergies by walking through a patient journey is key in understanding the patient and caregiver’s perspective. Shared decision making is a discussion tool that can be leveraged to help identify appropriate patients for peanut oral immunotherapy and to make treatment decisions that best align with what is most important to patients/ caregivers; including the patient’s/caregiver’s willingness, support-system, goals, values, and perspective. In addition, our faculty will close with sharing practical experiences in implementing oral immunotherapy.

Also, visit Aimmune Therapeutics at Booth #619.

Supported by an independent educational grant from ALK – Abello Inc

This program will provide an up-to-date review of recent studies supporting the use of allergen immunotherapy for allergic rhinitis and allergic asthma, allowing the attendee to be fully versed on recent studies related to the mechanism, efficacy and safety of both subcutaneous and sublingual immunotherapy. Issues impacting clinical practice will be reviewed, including patient adherence, patient selection and mitigating factors in favor of particular immunotherapy formats, based on both U.S. and international published data.

Moderator: Warner W. Carr, MD, FACAAI

Separate registration fee. Admission by ticket only. Attendees must be registered for the Annual Scientific Meeting to enroll in the Annual Literature Review.

Everything You Should Have Read Last Year but Didn't!

To help you keep abreast of the latest clinical developments in allergy and immunology, the College will continue its highly successful literature review program. It’s a review of the most important, clinically focused literature of our specialty published between November 2018 and October 2019, with emphasis on clinical relevance. Faculty includes allergy/immunology training program directors and specialists in practice.

Moderator: James T. Li, MD, PhD, FACAAI

This symposium will help the learner know what to investigate when referred a patient for anaphylaxis and no obvious trigger can be identified. The attendee will leave with a good approach to the differential diagnosis of recurrent idiopathic anaphylaxis and be able to initiate the appropriate management strategy for the same.

Moderators: Anne K. Ellis, MD, MSc, FACAAI, and Nicole M. Chase, MD, FACAAI

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

Moderator: Kay Tyler, MBA
 

Limit 54. Seats Available on first-come, first-served basis.

Whether you are just getting started or a seasoned veteran, this exciting interactive learning opportunity has something for you. Choose three of the six topics and spend 25 minutes with each expert addressing a phase of allergy practice. The expert will give a five-minute overview of the topic and will then answer questions and facilitate discussion with the table participants for 20 minutes.

Table Rotations: 8:05 am, 8:30 am, 9:00 am

Moderator: Kevin P. McGrath, MD, FACAAI

American Ninja Warrior: Artis Thompson III
8:30 – 9:30 am

Artis Thompson III grew up in a single-parent home where he watched his mom work two jobs to support him and his three siblings. He applies the work ethic and lessons he learned from her in his daily and professional life as a personal trainer, semi-pro football player and participant on American Ninja Warrior. As an extreme athlete and an amputee, he strives to be an inspiration to his community and to show everyone that they can do the things they love, no matter their personal situation.

Advanced Practice Health Care Providers Course requires separate registration. Admission by ticket only.

8:00 – 9:30 am
Moderator: Jodi Shroba, MSN, APRN, CPNP

10:00 – 11:30 am
Moderator: Amanda L. Michaud, PA-C

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

A look at how biologics can work in small, medium and large practice settings.

Speaker:
Jennifer Kuehn, CPC

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

Attendees will learn how current technologies and workflow techniques can be used to streamline the practice revenue cycle. Hear how a thriving Asthma & Allergy Center used these applications to increase revenue and decrease days in accounts receivable.

Speaker:
Charlie Furr

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

The new USP Chapter 797 standards on sterile compounding were released in June. Find out what your practice needs to do to be compliant with regards to allergen extract mixing. We’ll review the specific requirements for personnel qualifications, facilities and documentation. You’ll leave with all the information you need to ensure your practice is compliant with the new rules.

Speaker:
Kay Tyler, MBA

For some patients, use of rush or cluster immunotherapy can result in greater adherence and ultimate success. Identifying this patient population and preparing for potential side effects and practical impediments to their use of immunotherapy is essential in comprehensive allergy care.

Moderator: Ira Finegold, MD, FACAAI, and Joseph P. Forester, DO, FACAAI

Biologic therapy is increasingly important in the armamentarium of the allergist/immunologist. New biologics have been approved for treatment of severe asthma, atopic dermatitis and CRS, and new indications are being investigated, including food allergy.

Moderators: Jay A. Lieberman, MD, FACAAI, and William C. Anderson, MD, FACAAI

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

A look at how biologics can work in small, medium and large practice settings.

Speaker:
Jennifer Kuehn, CPC

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

Attendees will learn how current technologies and workflow techniques can be used to streamline the practice revenue cycle. Hear how a thriving Asthma & Allergy Center used these applications to increase revenue and decrease days in accounts receivable.

Speaker:
Charlie Furr

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

The new USP Chapter 797 standards on sterile compounding were released in June. Find out what your practice needs to do to be compliant with regards to allergen extract mixing. We’ll review the specific requirements for personnel qualifications, facilities and documentation. You’ll leave with all the information you need to ensure your practice is compliant with the new rules.

Speaker:
Kay Tyler, MBA

Supported by an independent educational grant from Aimmune Therapeutics

This symposium has been designed to aid attendees in their efforts to align their practice with current guidelines and expert recommendations and ensure that they are aware of the full complement of therapeutic options for helping patients manage their food allergies. In doing so, session participants will be better positioned to help patients who have or are at risk for food allergies avoid a lifetime of managing the substantial burden associated with avoiding the allergen and coping with the consequences of accidental exposures.

Moderators: Edwin H. Kim, MD, FACAAI, and Douglas Jones, MD, FACAAI

A recording of this session will be available after the Annual Meeting on the College Learning Connection.

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

This session will provide an update on regulatory changes as they apply to allergy and immunology practices and discuss the new USP 797 regulations and requirements, as well as upcoming changes to the physician fee schedule, MIPS, etc.

Speaker:
Bill Finerfrock

Advanced Practice Health Care Providers Course requires separate registration. Admission by ticket only.

ARS

This presentation will work through the diagnosis of tree nut allergy, including the use of component testing and oral challenges. In addition, we will discuss home management of tree nut allergy.

Speakers:
Jodi Shroba, MSN, APRN, CPNP
Maria Crain, CPNP, AE-C

From basic science to the clinical conundrums, this session will cover how to evaluate and manage patients with contact dermatitis.

Moderators: Sandra M. Gawchik, DO, FACAAI, and Stephanie Mawhirt, DO

Limit 45. Seats Available on first-come, first-served basis.

Every allergy practice can benefit from these pearls to help improve how your practice operates. Choose three of the five topics and spend 25 minutes with each expert addressing an aspect of allergy practice. The expert will give a five-minute overview of the topic and will then answer questions and facilitate discussion with the table participants for 20 minutes.

Table Rotations: 1:05 am, 1:30 am, 2:00 pm

Moderator: Stanley M. Fineman, MD, MBA, FACAAI

Advanced Practice Health Care Providers Course requires separate registration. Admission by ticket only.

This program will focus on tools and educational methods that can be used to help promote shared decision-making for asthma and allergic diseases between health care professionals and patients. The College's online shared decision-making tools will be used as examples.

Speakers:
Cheryl K. Bernstein, RN, CCRC
Maureen George, PhD, RN, AE-C

Separate registration fee. Admission by ticket only. Attendees must be registered for the Annual Scientific Meeting to enroll in the Annual Literature Review.

Everything You Should Have Read Last Year but Didn't!

To help you keep abreast of the latest clinical developments in allergy and immunology, the College will continue its highly successful literature review program. It’s a review of the most important, clinically focused literature of our specialty published between November 2018 and October 2019, with emphasis on clinical relevance. Faculty includes allergy/immunology training program directors and specialists in practice.

Moderator: David A. Khan, MD, FACAAI

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

Attendees will learn how to tackle culturally-entrenched processes that need updating and will be introduced to demonstrated tools that help with new process implementation such as Lean Methodology. We will provide examples for communicating why the process changes are being made to your clinic coworkers, who do not always welcome changes to their daily routines.

Speaker:
Scott Dennis, MHA

Bring your passport game card for a chance to win!

Booth #613

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

Not For Credit

Employee satisfaction and happiness assumes a larger role in retaining excellent staff than ever before. The practice of hiring and keeping key employees has drastically changed. This session will offer insights into new recruitment strategies and employee benefits that will keep your staff from moving on.

Speaker:
Lauren Sloan, MHA, RN

ARS

With the advent of commercial peanut allergy therapy, making a basic diagnosis of peanut allergy is essential. However, new and emerging diagnostic tests may complicate this process, and clinicians must be up-to-date on the indications for testing, what test to choose and how to interpret these tests. This session will review the current state of peanut allergy diagnostic testing, including potential applications of component testing and whether diagnostic testing can be used to infer future risk.

Moderators: Jay M. Portnoy, MD, FACAAI, and David B.K. Golden, MD, FACAAI

Advanced Practice Health Care Providers Course requires separate registration. Admission by ticket only.

Managing intermittent coughing and wheezing is part of any pediatric practice. Maintaining knowledge of the current treatment recommendations is essential, including when to start daily medications. This session will review guidelines and current thoughts regarding management.

Advanced Practice Health Care Providers Course requires separate registration. Admission by ticket only.

This presentation will present case studies of common immunological disorders, from presentation to diagnosis and management.

Speakers:
Brenda L. Snyder, APRN, CPNP
Nikita Raje, MD, FACAAI

MOC/CME

Provider health and wellness involves multiple issues, including provider stress, burnout and depression, which can lead to medical errors, early retirement, addiction, divorce and suicide. It has been shown that burnout issues start in medical school and progress through residency, fellowship and throughout a provider’s career. Many medical schools, residencies and allergy/immunology fellowships do not spend a lot of time on this issue during training, and, given the modern health care climate, physician/provider health and wellness is likely to continue becoming a more significant issue. This symposium will review the scientific literature about provider health and wellness and discuss the major causes of provider burnout and stress, along with potential solutions to alleviate this burden. Specific data regarding this topic among allergists/immunologists will be reviewed. This session can help allergy/immunology providers throughout their careers.

Moderators: Travis A. Miller, MD, FACAAI, and Andrew Nickels, MD, FACAAI

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Office Administrators Practice Management Course requires separate registration fee. Admission by ticket only.

ARS Not For Credit

This presentation will review the basic foundation of key leadership qualities in today’s business world. It will provide key concepts from leaders in today’s marketplace (such as John Maxwell, Richard Ryerson, Zig Ziglar, Jim Collins and others). It will provide participants an understanding of these key concepts, and through integration, it will improve the operational strategies of their medical practice. In addition, it will provide participants the opportunity to understand their leadership style and explore how this understanding will allow them to improve their practice management careers.

Speaker:
John Milewski

Not For Credit

Business meeting supported by Circassia

ARS

During the educational program, speakers will discuss anaphylaxis and primary immune deficiency. Knowledge about these diseases is ever-expanding and fellows are infrequently lectured on these subjects. Allergist/ immunologists-in-training will benefit from understanding these disorders, both for their board exams and for their future practices.

Moderators: Christin L. Deal, MD, and Miriam Samstein, MD, PhD

Supported by Aimmune Therapeutics

Supported by Aimmune Therapeutics

All registered attendees are invited to the ACAAI President’s Welcome Reception. Join us at Minute Maid Park, home of the Houston Astros! The main event will be in the park’s Union Station lobby, the grand entrance to Minute Maid Park, with an open bar and great food. You’ll get a great view of the field by stepping into areas of the covered concourse level and will have access to the infield warning track and dugouts. View the World Series trophy on the warning track by home plate from 6:00 – 7:00 pm. It all adds up to a home-run event!

Minute Maid Park is walking distance from the hotels. Transportation will not be provided. Enter ballpark at the Atrium Entrance off of Texas Street. Name badges must be worn for admittance to ballpark.

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Presented by:
Michael Wechsler, MD

Please join us on November 8 at 8:15pm as Michael Wechsler, MD of National Jewish Health in Denver presents a Non-CME program titled, A VR View: Severe Uncontrolled Asthma: Phenotypes, Endotypes, and Treatment Response Decisions. This program will include VR animations and will be of interest to any clinician who manages moderate-to-severe asthma.

Also, visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313.

Supported by ALK Inc.

Not For Credit

Presented by:
Don Bukstein, MD
Moises Calderon, MD
Brian Stone, MD
Tonya Winters

ALK-Abelló, Inc. will host a dessert reception, which includes 4 mini-presentations that illustrate today’s AIT candidate, monotherapy for polysensitized patients, realworld experience of SLIT-tablets, and expanding AIT in your practice to more patients.

$25 donations will be made to the Fellows-in-Training Travel Scholarship Fund through the American College of Allergy, Asthma & Immunology’s Foundation and to Allergy & Asthma Network for each participant attending all 4 mini-presentations.

Also, visit ALK Inc. at Booth #513.

Supported by ALK Inc.

Join us to connect with FITs and program directors from allergy/immunology programs from across the country. The session will include a panel discussion focused on careers in allergy/immunology. You’ll hear different perspectives on navigating career paths and early career opportunities.<

Panelists:

Mariana Castells, MD
Brigham & Women's Hospital
Boston, MA

Jonathan Corren, MD
Allergy, Asthma &Immunology Associates
Los Angeles, CA

Elena Perez, MD
Allergy Associates of the Palm Beaches
Palm Beach, FL

Hendrik Nolte MD, PhD
Senior VP of Research & Development Chief Medical Officer
ALK, Inc.

Speakers:
Todd A. Mahr, MD, FACAAI
David R. Stukus, MD, FACAAI
Mrs. Patricia Wedner, Alliance President

The 2019 Gold Headed Cane Award will be presented at this time to Dana V. Wallace, MD, FACAAI.

This session will address the evolution of evidence pertaining to conditions for which allergists play a central role in management. Attendees will hear discussion surrounding new guidelines, new conditions and new approaches to longstanding beliefs.

Moderator: Todd A. Mahr, MD, FACAAI, ACAAI President

Fine Jewelry with Vincent Peach
8:30 – 9:30 am

Coming from a long line of prominent US jewelers and “pearl men,” Vincent Peach has honed his ancestral expertise into unique, truly organic fine jewelry creations. Vincent handcrafts truly one-of-a-kind fine jewelry pieces featuring rare pearls, brilliant diamonds, precious metals and exotic leathers. Join us for a trunk show and talk that highlights the Vincent Peach jewelry collection, combining the casual elegance of leather and the extraordinary beauty of diamonds and pearls.

Bring your passport game card for a chance to win!

Booth #613

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Supported by AstraZeneca

Not For Credit

Presented by:
Reynold A Panettieri, MD

This program will examine the relationship between shortacting 2-agonist (SABA) reliance, patient behavior, and asthma morbidity. An understanding of SABA reliance and its consequences highlights an unmet need and an opportunity to optimize control.

Also visit AstraZeneca at Booth #301.

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Presented by:
Neal Jain, MD

Listen to an expert clinician discussion an add-on maintenance treatment for patients with moderateto- severe asthma aged 12 years and older with an eosinophilic phenotype or oral corticosteroid-dependent asthma. Our presenter will highlight key roles for Type 2 Inflammation in the pathobiology of asthma and the efficacy and safety data across three clinical trials in nearly 3,000 patients with asthma. Additionally, our presenter will lead an interactive discussion of different patient types who might be eligible for treatment.

Also visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313.

Supported by GlaxoSmithKline

Not For Credit

Presented by:
Dennis K. Ledford, MD

Join us for an engaging program exploring the role of eosinophils in disease management. We will examine key efficacy and safety data for a treatment that reduces eosinophils, including long-term data in patients with severe asthma. We will also discuss clinical approaches for identifying appropriate patient types that may benefit from a targeted treatment to reduce eosinophils.

Also visit GlaxoSmithKline at Booth #1012.

Allied Health Professionals Course requires separate registration. Admission by ticket only.

Supported by an independent educational grant from Aimmune Therapeutics

Moderator: Maureen George, PhD, RN, AE-C

Invitation only. All division directors and training program directors are invited.

This panel discussion is a program of the Joint Task Force on Academic Allergy/Immunology, which was created to evaluate needs and develop tools and strategies to support the success of academic allergy/immunology divisions. The interactive session will discuss challenges and opportunities facing A/I divisions within academic medical centers. There will be opportunity for significant audience involvement to discuss challenges, successes and opportunities at your center with other academic leaders.

Moderator: Bryan L. Martin, DO, FACAAI, and Aidan A. Long, MD

Supported by an independent educational grant from Teva Pharmaceuticals

Despite advances in pharmaceutical management of asthma, patients continue to have high frequency of health care utilization due to poor control of asthma symptoms and frequent exacerbations. Many factors are thought to contribute to this, with poor adherence to medical treatment felt to be a major factor. Adherence to asthma medications has historically been very poor, particularly with inhaled medications. Also, poor recognition of symptoms has frequently been found in a subset of patients with chronic asthma, leading to poor outcomes. Digital technology has the opportunity to address many of these issues. Mobile apps are being developed specifically for patients with asthma, including both educational and self- and remote-monitoring functions. New inhalers are being developed that contain chips to provide real-time feedback at the time of use. Digital technology has the opportunity to reduce health and social inequities incurred by the disease.

Moderators: Jared Darveaux, MD, and Mark C. Stahl, DO, FACAAI

ARS

Multiple new studies have been published that show the potential benefit of specific interventions in preventing the development of atopic dermatitis and food allergies. Allergists need to remain at the forefront of this research and understand how to implement evolving data into clinical practice. This session will utilize case-based discussions to review the most up-to-date evidence and provide practical talking points to help educate parents and primary care providers.

Moderators: Angela D. Hogan, MD, FACAAI, and Bruce J. Lanser, MD, FACAAI

Oral food challenges are the gold standard to diagnose food allergy. However, oral food challenges are underutilized in clinical practice. This session will address the challenges of implementing oral food challenges into clinical practice, with particular focus on performing food challenges in infants, as well as a review of anaphylaxis management in infants.

Moderators: Anne K. Ellis, MD, MSc, FACAAI, and Matthew Greenhawt, MD, MSc, MBA, FACAAI

ARS MOC/CME

From skin-deep to outward, this session will discuss the etiology, management and evaluation of patients with severe cutaneous drug eruptions.

Moderators: Leonard Bielory, MD, FACAAI, and Joseph A. Bellanti, MD, FACAAI

Fee: $195 (FITs: $50 / AHP: $50). Limit 32.

Supported by RMS Medical Products through an independent educational grant consisting of loaned durable equipment and disposable supplies.

Clinicians frequently prescribe gamma globulins for antibody deficiencies but are not very familiar with the administration of immunoglobulins. However, their oversight of these infusions is important. This workshop will provide instruction on administration of IV SQ in order to facilitate SQ and assist clinicians in determining the best product for each patient.

Moderators:
Lisa J. Kobrynski, MD, MPH, FACAAI
Kenneth Paris, MD, MPH

Faculty:
Nikita Raje, MD, FACAAI
Richard L. Wasserman, MD, PhD, FACAAI
Nicholas Rider, DO
Lisa R. Forbes, MD

Bring your passport game card to the Exhibit Hall for a chance to win!

2020 Annual Meeting Program Committee

Supported by Aimmune Therapeutics

Not For Credit

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Not For Credit

Looking for new opportunities, an associate for your group or a buyer for your practice? The Doctors’ Job Fair brings together all interested parties seeking or offering professional opportunities.

Supported by AstraZeneca

Not For Credit

Presented by:
Warner Carr, MD

Please join us to learn more about ways to help identify eosinophilic asthma through a combination of clinical features, patient history and measurements of eosinophils told through three compelling patient case studies. Hosted by a national expert, explore a targeted treatment approach for patients with both efficacy and safety profile data.

Also visit AstraZeneca at Booth #301.

Supported by CSL Behring

Not For Credit

Presented by:
Raffi Tachdjian , MD, MPH
Zahra Khan (HAE Patient Advocate)

Join us as we present newly published data from the Open Label Extension Study following patients long term. Hear from an HAE opinion leader and an HAE patient as they talk about the impact of HAE and successfully managing the disease.

Also visit CSL Behring at Booth #123.

Supported by Novartis Pharmaceuticals Corporation

Not For Credit

Allergic asthma is a specific phenotype of a common disease with wide heterogeneity. Associated comorbidities often go hand-in-hand with the condition. Such comorbidities may share common immunopathological mechanisms with asthma that can influence its control. Immune Response Pathways: Characteristics of Asthma and Comorbidities will focus on the immune response of allergic asthma, accurate recognition of these characteristics and proper management of comorbidities.

Also visit Novartis Pharmaceuticals Corporation at Booth #1213.

Not For Credit

ACAAI, ABAI and diplomates are key stakeholders in the current transformation of allergy/immunology continuing certification. This session will provide attendees an overview of the current landscape of continuing board certification, an update on the continuous assessment program (CAP) and personal progress meter. An interactive town hall will be held during this session, as part of ABAI’s commitment to co-development of specialty-continuing certification.

We have an expanding supply of tools for managing the noninfectious complications of CVID. Understanding the availability and utility of these tools will help practitioners in the diagnosis and treatment of the noninfectious complications of CVID.

Moderators: Nikita Raje, MD, FACAAI, and Benjamin Prince, MD, MSci

MOC/CME

Several new interventions are likely to be approved by the FDA in the upcoming year. These therapies have different levels of efficacy and side effects and will likely greatly impact office flow. Thus, it is imperative that allergists become more facile with their knowledge regarding these therapies.

Moderators: John J. Oppenheimer, MD, FACAAI, and Marcus Shaker, MD, MSc, FACAAI

The healthy allergy and immunology clinic involves more than just keeping the schedule full. An unhealthy clinic can contribute to the allergist’s stress level, burnout and depression, as well as poor patient satisfaction, compliance and outcomes. In this session, find out what constitutes an unhealthy work environment in the clinic and learn how to use the principles of integrative medicine to improve the health of the clinic and, consequently, of our patients and ourselves as providers.

Moderators: Janna M. Tuck, MD, FACAAI, and Meagan W. Shepherd, MD, FACAAI

Allied Health Professionals Course requires separate registration. Admission by ticket only.

Food allergies have a significant impact on quality of life. It is important, as allied health providers, that we consider a holistic approach to patient care. Participants will be given practical, useful tips to help families manage daily activities including school, holiday parties and family events.

Allied Health Professionals Course requires separate registration. Admission by ticket only.

This session will discuss common questions, misconceptions and urban myths encountered in the allergy practice. Topics include foods, medications, vaccines and other frequentlyfound myths regarding allergies.

Speakers:
Amanda L. Michaud, PA-C
Abby L. Allen, RN, NP

COPD is the third leading cause of death in the United States, and our specialty is encountering both diagnosed and undiagnosed COPD patients at an increased rate. Allergy/immunology specialists are in a unique position to be at the forefront of COPD care, including evaluating potential immune deficiencies in this patient population. In addition, many patients may have asthma-COPD overlap (ACO), and there is still considerable debate in the medical community regarding the exact diagnosis and treatment of this condition.

Moderators: Anil Nanda, MD, FACAAI, and Michael B. Foggs, MD, FACAAI

This session will provide the allergist/immunologist a perspective on the diversity of food allergy along racial, ethnic and socioeconomic lines. There will be particular focus on associations with morbidity and mortality, what diverse families may value regarding food allergy, how they may choose to spend their health care dollars and how this may differ from the primarily white, middle class families typically described in food allergy.

Moderators: Cherie Y. Zachary, MD, FACAAI, and Princess Ogbogu, MD, FACAAI

Limit 45. Seats Available on first-come, first-served basis.

These expert round table discussions will address some of the threats and potential pitfalls of allergy practice today. Choose three of the five topics and spend 25 minutes with each expert addressing a phase of allergy practice. The expert will give a five-minute overview of the topic and will then answer questions and facilitate discussion with the table participants for 20 minutes.

Table Rotations: 1:05 pm, 1:30 pm, 2:00 pm

Moderator: Warner W. Carr, MD, FACAAI

Fee: $50. Limit 25. Allied Health and Advanced Practice Program registrants only.

Studies have demonstrated that hands-on practice, offered by case simulations, is more effective than standard classroom instruction for emergency situational training. Simulations allow health care professionals to practice crisis management and teamwork skills to increase confidence in life-threatening emergencies such as anaphylaxis.

Moderators:
Anne K. Ellis, MD, MSc, FACAAI
Sara Barmettler, MD

Speakers:
Marcella R. Aquino, MD, FACAAI
Aleena Banerji, MD
Kimberly G. Blumenthal, MD, MSc

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Supported by Optinose

Not For Credit

Presented by:
Shahnaz Fatteh, MD

Explore a unique patient case to understand how XHANCE is a different treatment approach.

Also visit Optinose at Booth #1021.

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Presented by:
Eli O. Meltzer, MD

Please join Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. for a Product Theater presentation at the ACAAI Conference, located on the exhibit floor. Food and beverage to be served.

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc., Booth #313

Allied Health Professionals Course requires separate registration. Admission by ticket only.

Anaphylaxis is a life-threatening reaction that can occur from ingestion of allergenic food or injection of immunotherapy. This medical emergency can occur in the office, and it is important that all office staff are prepared to treat. This session will provide case studies and review treatment.

ARS

This session will address cannabis legalization and patient perceptions and patterns of use. We will discuss how cannabis is commonly used, review the importance of asking our patients about cannabis use, the effects of cannabis on the lungs (also versus tobacco) and review allergic sensitization to cannabis. Common misconceptions will be discussed, including the ideas that cannabis is “good” for asthma, that it is safer than tobacco, that it is not addictive and that cannabis allergy does not exist. Attendees will gain a greater understanding of cannabis and its effects, so they can instantly bring this knowledge to their clinical practice in order to empower their patients and advocate for their well-being.

Moderators: William S. Silvers, MD, FACAAI, and Michael R. Rupp, MD, FACAAI

This session will address relevant changes, modifications and implementation of CPT and ICD-10 coding for 2019 and the AMA’s outlook for medicine. This will be accomplished by practical case-based scenarios focused on how the change may affect the practice of allergy and clinical immunology. In addition, we’ll review the state of politics and the national perspective of medicine as seen through the eyes of the AMA. Finally, we’ll offer an update on the changing landscape on Capitol Hill as it relates to the current state of government.

Moderators: James M. Tracy, DO, FACAAI, and Stephen A. Imbeau, MD, FACAAI

Supported by an independent educational grant from Merck & Co., Inc.

Cough is one of the most common symptoms of patients seen by allergist/immunologists. Understanding the mechanisms that lead to cough is paramount. A new paradigm has emerged of patients with cough (neural) hypersensitivity that does not respond to asthma, rhinitis and/or GERD therapy. Allergists need to understand the different therapeutic agents and their mechanisms of action in all stages of cough.

Moderators: Jeremy S. Katcher, MD, FACAAI, and J. Wesley Sublett, MD, MPH, FACAAI

A recording of this session will be available after the Annual Meeting on the College Learning Connection.

Supported by an independent educational grant from Abbvie

This session will consider treatment of the itch in persons with atopic dermatitis. Should allergists prescribe monoclonal antibodies or drugs that block neurotransmitters?

Moderators: Myron J. Zitt, MD, FACAAI, and Allison C. Ramsey, MD, FACAAI

Allied Health Professionals Course requires separate registration. Admission by ticket only.

This activity is supported by Micro Direct, Inc. through an independent educational grant consisting of disposable supplies.

This session will combine the popular spirometry workshop with this year’s focus on advancing your skills to improve patient’s performance of spirometry. There will be a handson opportunity to practice with spirometry machines. The second portion of this presentation will discuss other types of tests that may be performed to answer the clinical question.

This session will review the newly published jointly developed AGA/AAAAI/ACAAI GRADE-based EoE guidelines discussing the new clinical recommendations and areas of emerging evidence. There will be particular emphasis on how the allergist and gastroenterologist can co-manage this illness.

Moderators: John J. Oppenheimer MD, FACAAI, and Dana V. Wallace, MD, FACAAI

Fee: $150 (FITs: $50 / AHP: $50). Limit 25.

Studies have demonstrated that hands-on practice, offered by case simulations, is more effective than standard classroom instruction for emergency situational training. Simulations allow health care professionals to practice crisis management and teamwork skills to increase confidence in life-threatening emergencies such as anaphylaxis.

Moderators:
Anne K. Ellis, MD, MSc, FACAAI
Sara Barmettler, MD

Faculty:
Marcella R. Aquino, MD, FACAAI
Aleena Banerji, MD
Kimberly G. Blumenthal, MD, MSc

Not For Credit

Moderators: Brian T. Kelly, MD, FACAAI, and David R. Stukus, MD, FACAAI

Not For Credit

Moderators: Lisa J. Kobrynski, MD, MPH, FACAAI, and Janna M. Tuck, MD, FACAAI

Supported by DBV Technologies

Not For Credit

Test your knowledge, sharpen your wits and join in the fun at the dynamic, fast-paced FIT Bowl! Participating teams from training programs around the country will compete to answer a variety of serious (and not so serious) questions posed by an expert panel. Approximately 30 teams from the US and Mexico will participate in this popular game show.

Supported by Teva Pharmaceuticals

Not For Credit

Presented by:
Gregory W. Bensch, MD
Nabeel Farooqui, MD
Warner W. Carr, MD
Maeve O’Connor, MD

Join an expert panel for an interactive program about the use of digital technology and the role of objective inhaler use data in asthma patient care. Learn about how inhaler use data may inform patient consultations. Attendees may also engage in a hands-on demonstration of an e-connected inhaler.

Also, visit Teva Pharmaceuticals at Booth #113.

Supported by Genentech and Novartis Pharmaceuticals Corporation

Not For Credit

Presented by:
Thomas B. Casale, MD
Jonathan Corren, MD

Test your asthma knowledge! The Allergic Asthma Challenge gives you an opportunity to compete against your colleagues in a trivia format. Questions and educational content will focus on asthma phenotypes and endotypes, asthma biomarkers, and the role of IgE in allergic asthma. We look forward to seeing you there!

Also, visit Genentech and Novartis Pharmaceuticals Corporation at Booth #713.

Supported by GlaxoSmithKline

Not For Credit

Presented by:
Nicola Hanania, MD
Nestor Molfino, MD

Eosinophils play an important role in airways inflammation and proposed phenotypes in asthma and COPD. This program will review the biology of eosinophils and cellular-mediated mechanisms of airway inflammation. Use of eosinophils to identify subpopulations as well as guideline recommendations for incorporation of phenotyping into clinical practice will be highlighted.

Also, visit GlaxoSmithKline at Booth #1012.

Supported by an independent educational grant from GlaxoSmithKline

Pediatric asthma is one of the most common chronic diseases in children. There is a continued need to understand best practices to improve the care of these children. Understanding how the environment plays a role in pediatric asthma is key in providing better control for our patients. How does climate change affect pediatric asthma? How can we improve the indoor environment to decrease flare-ups of pediatric asthma? Biologics are playing a major role in severe asthma in adults, but where do they play a role in children with asthma? What are the benefits and risks for the pediatric population? What are the new biologics we may see in children? With the Asthma Controller Step Down Yardstick in Pediatric Asthma, how does an allergist decrease medications in asthma in the pediatric population? When is it safe to decrease controller treatments, and how do you monitor the child after you decrease it?

Moderators: William C. Anderson, MD, FACAAI, and Alan Goldsobel, MD, FACAAI

MOC/CME

The advent of targeted therapies and further understanding of the microbiome offer exciting opportunities for new approaches to patients with asthma and allergic conditions. However, knowledge gaps continue to exist. This session will review what we've learned, what we have yet to learn and, most importantly, what can be implemented now.

Moderator: Mark L. Corbett, MD, FACAAI

Gentle Morning Workout
8:30 – 9:30 am

Greet the day with a gentle work out to stretch your muscles and calm your mind with Houston’s very own Cathy Wertheimer, MEd, ACSM! Cathy will be leading a custom-tailored workout created specifically for Alliance members in the Hospitality Suite.

Fee: $300 (FITs: $150 / AHP: $150). Limit 120. Admission by ticket only.

Supported by an independent educational grant from Stallergenes Greer

This inaugural program will offer didactic presentations, developed specifically to detail the expectations of the revised USP 797, followed by a hands-on workshop, where attendees will accurately garb to meet 797 standards, participate in area sterilization techniques and perform individualized media fill and glove tip testing. The session will conclude with a brief exam, and certificates of completion will be awarded to those who successfully complete the training program.

Moderator: Bryan L. Martin, DO, FACAAI

Document Editor: Peter Mustillo, MD

Bring your passport game card for a chance to win!

Booth #613

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Supported by Pfizer, Inc.

Not For Credit

Presented by:
Ankmalika Gupta, MD

Join us for an interactive presentation on a steroid-free topical therapy for the treatment of mild-to-moderate atopic dermatitis. Expert faculty will guide the audience through an in-depth look into the product and answer questions to help attendees gain a better understanding of this treatment option.

Also visit Pfizer, Inc. at Booth #1013.

Each of the 7 presenters will have only 11 minutes to deliver insightful, targeted and dynamic information on their assigned topics.

Moderators: Todd A. Mahr, MD, FACAAI

Allied Health Professionals Course requires separate registration. Admission by ticket only.

Supported by an independent educational grant from Aimmune Therapeutics

Moderator: Helen M. Murphy, RRT, AE-C

Supported by an independent educational grant from CSL Behring

This session will help participants recognize the key features that impact the disease burden and outcomes for patients with primary immune deficiencies. Early recognition of these issues can help to reduce their impact on patient’s wellbeing and, by reducing disease related morbidity, improve patient outcomes.

Moderators: Purvi S. Parikh, MD, and Kenneth Paris, MD, MPH

MOC/CME

Any allergist that mixes allergy vaccines should be following the guidance of USP 797. Recent issues, unrelated to allergy vaccine preparation, have caused the USP to alter its requirements for drug compounding. Though initially allergy mixing seemed as though it might be consumed by the “compounding” controversy, the ACAAI and others worked to demonstrate the differences between mixing allergy vaccines in an allergist’s office and the compounding of pharmaceuticals by commercial compounding companies. Although the efforts of the ACAAI Advocacy Council and others were largely successful, changes to the USP 797 requirements for the mixing of allergy vaccines did occur. This symposium will review the history of the issue, address the changes and suggest operational recommendations for implementation of these changes.

Moderators: Richard G. Gower, MD, FACAAI, and Erika Gonzalez-Reyes, MD, FACAAI

Fee: $80 (FITs: $35). Limit 50.

This workshop will provide attendees with the ability to discuss the surgical anatomy of the upper airway, including the nasal cavity, pharynx and larynx; identify normal and abnormal anatomy, as well as disease presentations and postoperative changes found with endoscopic examination of the upper airway; and identify the indications for, and the use of, the fiber-optic rhinoscope in the allergist’s office.

Faculty:
Jerald W. Koepke, MD, FACAAI
Seong H. Cho, MD, FACAAI

Fee: $150 (FITs: $50 / AHP: $50). Limit 45..

Supported by SmartPractice through an independent educational grant consisting of disposable supplies.

This will be a hands-on workshop demonstrating techniques in dermatology: patch testing, skin biopsy, physical urticaria challenges and wet wraps. Some case studies may be used to set the stage, but the focus will be hands-on stations. Attendees may select the stations of their choice.

Moderator: Kelly M. Maples, MD, FACAAI

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Bring your passport game card to the Exhibit Hall for a chance to win!

Supported by Stallergenes Greer

Registration required.

Supported by Genentech and Novartis Pharmaceuticals Corporation

Not For Credit

Supported by AstraZeneca

Not For Credit

Presented by:
Reynold A Panettieri, MD

Join us for an educational program exploring the mechanistic role of eosinophils in severe asthma. This interactive presentation will review updated guidance in assessing severe asthma, examine the role of eosinophils in severe asthma, and highlight the impact of oral corticosteroid (OCS) use in severe uncontrolled asthma.

Also visit AstraZeneca at Booth #301.

Not For Credit

Presented by:
Jonathan A. Bernstein, MD
Lawrence D. Sher, MD

Come learn about clinical efficacy, safety information, MOA, and dosing and administration, and how DUPIXENT may help your patients.
 

Also visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc. at Booth #313.

Supported by Novartis Pharmaceuticals Corporation

Not For Credit

Presented by:
Bradley E. Chipps, MD

In this presentation, Dr. Bradley Chipps will discuss the multiple pro-inflammatory pathways involved in asthma pathophysiology, reviewing established mediators such as IgE, IL-4/IL-13 and IL-5, as well as covering new science surrounding DP2 as a major regulator of the inflammatory cascade. The presentation will also explore the impact of persistent inflammation on downstream structural effects and, ultimately, clinical manifestations of asthma that remain poorly controlled in many patients.

Also visit Novartis Pharmaceuticals Corporation at Booth #1003.

Registration required. Fee $30. Limit 50.

Spouses and alliance members are invited to attend the Alliance Brunch and business meeting.

The Grove Houston
1611 Lamar St.

Moderators: Kevin Kelly, MD, FACAAI, and Stephanie Mawhirt, DO

Moderators: Mitchell Grayson, MD, FACAAI, and Michelle Maciag, MD

Moderators: Peck Ong, MD, FACAAI, and Peter Capucilli, MD

Transition is challenging for anyone, and different ages present different needs. This session will review unique aspects affecting children, adolescents and elderly patients who have asthma, food allergies and other allergic conditions. From discussion with caregivers to practical tips to help prepare for self-management, this session will provide an overview and a blueprint that attendees can immediately apply to patient care.

Moderators: Dana V. Wallace, MD, FACAAI, and Kelly M. Maples, MD, FACAAI

Limit 40. Seats available on first-come, first-served basis.

Supported by an independent educational grant from GlaxoSmithKline

An interactive PBL presentation of an older asthmatic patient with poor adherence to asthma medication and inadequate communication will be presented. These are critical problems in asthma care in the older patient because they contribute to morbidity and mortality through poor control, frequent asthma exacerbations, acute care visits and oral corticosteroid usage. The elderly asthmatic is particularly vulnerable and needs a shared decision-making to improve adherence. To improve patient adherence in the older asthmatic, clinicians need to consider a variety of factors and implement strategies directly targeting underlying issues that may be specific to the older patient. Strategies will be discussed, including customizing and simplifying learning and intervention regimes, identifying barriers to adherence and addressing them, ensuring patient support structures are in place and improving self-efficacy and health literacy through shared decision-making.

Moderators: Ray S. Davis, MD, FACAAI

ARS MOC/CME

Clinicians are often presented with patients complaining of recurrent infections; however, basic workup including serum immunoglobulins and specific antibodies may fail to demonstrate evidence of any immune deficiency. This clinical conundrum will review the presentation of these causes and the diagnostic workup. Treatment may include supportive therapies, and this clinical conundrum will review treatment options.

Moderators: Sami L. Bahna, MD, DrPh, FACAAI

New discoveries in atopic dermatitis are advancing our understanding of the underlying causes of this complex disease, as well as its role in allergic disease. New therapies give clinicians a wider range of treatment options to target specific manifestations of the disease and implement possible prevention strategies. This symposium will report on what we are learning from the new frontier of atopic dermatitis toward optimal care of the patient.

Moderators: Todd A. Mahr, MD, FACAAI, and Ignacio J. Ansotegui, MD, PhD

Allied Health Professionals Course requires separate registration. Admission by ticket only.

This presentation will focus on the new guidelines regarding the diagnosis and management of EoE. It will also discuss other non-IgE-mediated food disorders.

Speakers:
Raquel Durban, MS, RD, CSP, LDN
Abby L. Allen, RN, NP

Fee: $195 (FITs: $50 / AHP: $50). Limit 30.

Supported by Optim LLC through an independent educational grant consisting of loaned durable equipment and disposable supplies.

This workshop will provide attendees with the ability to describe the major anatomical structures of the nasal, pharyngeal and glottic areas as visualized during examination with the fiber-optic rhinolaryngoscope; describe variations of normal seen when participants examine one another in this hands-on session; and demonstrate the proper handling and initial skills needed to perform a comprehensive upper airway examination with a fiber-optic endoscope.

Moderator:
Jerald W. Koepke, MD, FACAAI

Faculty:
Seong H. Cho, MD, FACAAI
Kevin R. Murphy, MD, FACAAI
Grant C. Olson, MD, FACAAI
Donald W. Pulver, MD, FACAAI
David Elkayam, MD

Must be registered for the Allergen Extract Mixer Training Program – Full Day Session to attend.

Agar plates, media fill incubation and analysis provided by Eagle Analytical

This inaugural program will offer didactic presentations, developed specifically to detail the expectations of the revised USP 797, followed by a hands-on workshop, where attendees will accurately garb to meet 797 standards, participate in area sterilization techniques and perform individualized media fill and glove tip testing. The session will conclude with a brief exam, and certificates of completion will be awarded to those who successfully complete the training program.

Faculty:
Maureen M. Petersen, MD, FACAAI
Bryan L. Martin, DO, FACAAI
Rekha P. Raveendran, MD
James M. Tracy, DO, FACAAI
Michael R. Nelson, MD, PhD, FACAAI
Warner W. Carr, MD, FACAAI
Tara Doran, RN, BSN, MHA
Allie Rodriguez
Lori Lesiak, CMA (AAME) AE-C
Peter Mustillo, MD

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Moderators: Michael Pistiner, MD, MMSc, FACAAI, and Marissa Shams, MD, FACAAI

Moderators: Myron Zitt, MD, FACAAI, and Jared Darveaux, MD

Moderators:  Desiree Larenas - Linnemann, MD and Brittanie Neaves, MD

It has been well established that 10% of the general population reports having a penicillin allergy, but 90% of those individuals are not truly allergic. Allergists can be exceptionally useful in the education surrounding penicillin allergy and assessment through skin testing and oral challenges. This symposium will discuss how allergists can serve as experts and advocates in their community, regardless of their practice setting, in the communication and development of a penicillin allergy reconciliation program.

Moderators: David R. Stukus, MD, FACAAI, and Allison Ramsey, MD, FACAAI

Limit 40. Seats available on first-come, first-served basis.

Following a real-time assessment of the audience discussion of the PBL case, Dr. Meadows, Dr. Gross and the audience will interactively discuss proper coding and documentation for the patient.

Moderator: Don A. Bukstein, MD, FACAAI

MOC/CME

The technology involved in telemedicine, direct-to-consumer platforms and case examples of actual technology will be discussed and reviewed. This expert presentation will spark your interest in exploring the future of telemedicine.

Moderators: Jay M. Portnoy, MD, FACAAI, and Justin C. Greiwe, MD, FACAAI

Allied Health Professionals Course requires separate registration. Admission by ticket only.

This presentation will discuss the ever-growing use of e-cigarettes and marijuana and the possible effects it can have on our patients with atopic disease. It will also discuss the potential for development of allergic reactions to these products.

Fee: $195 (FITs: $50 / AHP: $50). Limit 30.

Supported by Optim LLC through an independent educational grant consisting of loaned durable equipment and disposable supplies.

The following criteria must be met to qualify for participation in this workshop:

• Have taken the Introductory Rhinolaryngoscopy Course at a prior meeting or have received similar training.
• Have a basic working knowledge of the nasal and laryngeal anatomy.
• Be familiar with the use of and have performed examinations with a flexible fiber-optic rhinoscope.
• Be willing to be examined by course participants.

Moderator:
Jerald W. Koepke, M

Faculty:
Seong H. Cho, MD, FACAAI
Grant C. Olson, MD, FACAAI
Kevin R. Murphy, MD, FACAAI
Donald W. Pulver, MD, FACAAI
David Elkayam, MD

Town Hall Meeting hosted by House of Delegates
4:45 – 5:30 pm

Not For Credit

Beer, wine and cheese reception. All meeting attendees welcome!

Annual Business Meeting
5:30 – 6:30 pm

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

The College invites all members to attend.

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

Not For Credit

Presented by:
Peter A. Lio, MD
Anne Marie Singh, MD

In this Interactive Exchange™ dinner program, faculty will review the pathophysiology of atopic dermatitis, and discuss clinical characteristics, and comorbid conditions. Experts will describe appropriate use of systemic treatment options, including biologic therapy. Attendees of this program will gain a fresh perspective on management strategies for patients with moderate-to-severe disease.

Also, visit Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.at Booth #313.

Allergists are well trained in the diagnosis and medical management of various allergic conditions. However, allergists can also play a central role in addressing other important aspects of these conditions that patients face in their daily lives. Allergists can lead the charge in educating other medical professionals and promoting quality care while also generating interest in our specialty among the next generation of physicians.

Moderator: Luz S. Fonacier, MD, FACAAI

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

This session will update the participant on the current state-of-the-art regarding spontaneous urticaria and physical or inducible urticarias. A comprehensive overview of the pathophysiology, differential diagnosis and treatment strategies will be discussed. The participant will gain an understanding of the various treatment guidelines referred to in the U.S. and Europe. At the end of this session, the participant will have an understanding of the approach to diagnosis and treatment of patients with spontaneous and inducible urticarias.

Moderators: Sandra M. Gawchik, DO, FACAAI, and Jonathan S. Tam, MD, FACAAI

MOC/CME

Our changing climate has impacted not only our temperatures, but the onset and duration of pollen season as well. It is important for allergists to understand the impact that climate change is having on our patients and to anticipate changes to how we provide care. Natural disasters create many challenges and are extremely disruptive to people’s lives. An often-neglected aspect of natural disasters includes the impact that flooding, fires and severe weather can have on the health of people with asthma and allergic conditions. Allergists who care for patients in natural disaster-prone areas can help them prepare for when those disasters strike.

Moderators: William K. Dolen, MD, FACAAI, and Meagan W. Shepherd, MD, FACAAI

The CAP Review is a literature-style review covering most of the articles chosen by the ABAI for the current six-month cycle of the Continuous Assessment Program (CAP). Each presenter will focus on key aspects of the study design, results and implications for practice. The goal of this session is to help prepare attendees for the second cycle of ABAI CAP program.

Moderator: Lisa J. Kobrynski, MD, MPH, FACAAI

Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.

MOC/CME

This session will provide a foundation for exploring newer medical, surgical and biologic therapies for chronic rhinosinusitis (CRS) with and without nasal polyps. Etiology, diagnosis and management will be reviewed.

Moderators: Alan B. Goldsobel, MD, FACAAI, and Puneet Shroff, MD, FACAAI

Common issues in managing the care of patients with primary immunodeficiencies will be addressed.

Moderators: Mary Beth Fasano, MD, MSPH, FACAAI, and S. Shahzad Mustafa, MD, FACAAI